Beacon Biologics

Beacon Biologics is a life sciences and healthcare organization launched by Versiti to supply well-characterized human biomaterials for research and cell therapy development. The business provides customized LeukoPaks, blood products, and related donor-selection and collection services to researchers, medical institutions, and novel cell therapy manufacturers. Its offering is built on Versiti’s blood collection network, apheresis capabilities, and blood-focused research infrastructure, including support for donor matching criteria such as high-resolution HLA typing and CMV status. Beacon Biologics appears to operate primarily as a commercial biomaterials and research-enablement service rather than as a therapeutics developer with an internal drug pipeline. The organization is positioned to help accelerate development of treatments across cancer, autoimmune, and other rare diseases.